India (Commonwealth Union)_ A 57-year-old Kenyan woman successfully completed chemotherapy and immunotherapy treatment for her Stage-IV endometrial cancer, which is a cancer of the inner lining of the uterus, at the Indraprastha Apollo Hospitals in New Delhi. The patient was diagnosed with endometrial cancer one year prior to undergoing surgery in Kenya in November 2021. However, following the surgery, the cancer progressed to other organs and the patient had further difficulties, including major disease in the abdomen and pelvis, fluid in both lungs, liver metastases, a non-healing abdominal surgical incision, and blood clots in her legs.
Following her deteriorating condition and illness impacting her whole health, she was finally sent to Indraprastha Apollo Hospitals, where she was hospitalized under the supervision of senior consultant and surgical oncologist Dr. Shuaib Zaidi. She was initially administered chemotherapy under the supervision of Dr. Ajay Gupta, who is a senior consultant in medical oncology at Indraprastha Apollo Hospitals.
According to Dr. Zaidi, endometrial cancer is normally detected at an early stage owing to frequent irregular vaginal bleeding, but in rare cases, it can reach Stage-IV without being detected. In the majority of cases with Stage IV endometrial cancer, the disease can progress too far for surgical removal, necessitating chemotherapy and immunotherapy for treatment. Following surgery for Stage-IV endometrial cancer in Kenya, this patient reported substantial peritoneal deposits in the abdomen and pelvis, chest nodes, fluid in both lungs, severe illness in the liver, a non-surgical incision, and clots in both legs.
During admission, the patient was extremely frail and exhausted owing to several health difficulties. She was brought to the hospital on January 20, 2022 for initial illness care, but since her condition deteriorated owing to a severe disease, chemotherapy and immunotherapy were recommended. “The patient required chemotherapy to fight the widespread disease process,” Dr. Gupta said. “Considering her poor health, we started with weekly chemotherapy. After two months of treatment, she showed reasonable physical improvement and the disease process had stabilized. The nuclear radioisotope FDG PET scan was also showing stable disease.”
